EQS: latest releases

• This will also be offered again as scrip dividend in shares or for cash distribution.\nEncavis AG (Prime Standard; ISIN: DE0006095003; ticker symbol: ECV) is a producer of electricity from renewable energies listed on the MDAX of Deutsche B\xc3\xb6rse AG.
• The Encavis Group\'s total generation capacity is currently around 2.8 gigawatts (GW), corresponding to a CO2 avoidance of 1.26 million tonnes p.a.
• Within the Encavis Group, Encavis Asset Management AG offers fund services to institutional investors.\nENCAVIS is a signatory of the UN Global Compact as well as of the UN PRI network.
• Encavis AG\'s environmental, social and governance performance has been awarded by two of the world\'s leading ESG rating agencies.

• Jan Mrosik, Chairman of the Executive Board of Knorr-Bremse AG: "Knorr-Bremse achieved outstanding results overall in the first quarter of 2021 despite the still volatile market environment.
• In addition, we\'ve further advanced our focus on ESG principles and implemented a number of further sustainability measures at Knorr-Bremse.
• "\nIn the first quarter of 2021, the Knorr-Bremse Group\'s order intake was higher than in the same quarter of the previous year for the third time in a row, improving by 13.3% to EUR 1,799 million (previous year: EUR 1,588 million).
• and 201 of the 2020 Annual Report of Knorr-Bremse AG (available at Investor Relations (knorr-bremse.com) ).\nKey Figures of Knorr-Bremse Group:\n'

b'Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group.\nThe issuer is solely responsible for the content of this announcement.\n'

• b'Dissemination of a Regulatory Announcement, transmitted by EQS Group.\nThe issuer is solely responsible for the content of this announcement.\nLONDON, 13 May 2021: Arix Bioscience plc ("Arix" or "the Company") (LSE:ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that it purchased the following number of its ordinary shares of 0.001 pence each on the London Stock Exchange from Jefferies International Limited as part of a buyback programme announced on 22 March 2021.\nArix intends to retain the purchased shares in treasury.\nFollowing settlement of the above purchase, Arix will have 132,653,800 ordinary shares of 0.001 pence each in issue (excluding 2,955,853 ordinary shares of 0.001 pence each held in treasury).
• This number represents the total voting rights in Arix and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority\'s Disclosure and Transparency Rules.\nIn accordance with Article 5(1)(b) of Regulation (EU) No.
• 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), the schedule below contains detailed information of the individual trades made by Jefferies International Limited as part of the buyback programme.\nFor more information on Arix, please contact:\n'

• b'Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
• If none, this should be stated.\nIs a Supplemental Form 8 attached?
• (Note 9) NO\n'

• b'Form 8.3 - The Vanguard Group, Inc.: Gamesys Group plc\nDissemination of a Regulatory Announcement, transmitted by EQS Group.\nThe issuer is solely responsible for the content of this announcement.\n(a) Full name of discloser:\n(b) Owner or controller of interests and short positions disclosed, if different from 1(a):\nThe naming of nominee or vehicle companies is insufficient.
• For a trust, the trustee(s), settlor and beneficiaries must be named.\n(c) Name of offeror/offeree in relation to whose relevant securities this form relates:\n(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:\n(e) Date position held/dealing undertaken:\nFor an opening position disclosure, state the latest practicable date prior to the disclosure\n(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?\nIf it is a cash offer or possible cash offer, state "N/A"\nIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.\n'

• b'Form 8.3 - The Vanguard Group, Inc.: Signature Aviation plc\nDissemination of a Regulatory Announcement, transmitted by EQS Group.\nThe issuer is solely responsible for the content of this announcement.\n(a) Full name of discloser:\n(b) Owner or controller of interests and short positions disclosed, if different from 1(a):\nThe naming of nominee or vehicle companies is insufficient.
• For a trust, the trustee(s), settlor and beneficiaries must be named.\n(c) Name of offeror/offeree in relation to whose relevant securities this form relates:\n(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:\n(e) Date position held/dealing undertaken:\nFor an opening position disclosure, state the latest practicable date prior to the disclosure\n(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?\nIf it is a cash offer or possible cash offer, state "N/A"\nIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.\n'

• Cryptology Asset Group (ISIN: MT0001770107; Ticker: CAP, formerly 4UD), a leading European investment firm for crypto assets and blockchain-related business models, announced its most recent estimated Net Asset Value ("NAV") per share of \xe2\x82\xac198.60.
• The stock was trading around \xe2\x82\xac137.00 this morning, roughly 31.0% below NAV.\nThe prior week was ripe with outstanding developments coming from Cryptology portfolio companies.
• In order to increase trading liquidity and open up to new shareholder groups, Cryptology is currently exploring an international listing.
• Noteworthy portfolio companies include crypto-giant and EOSIO software publisher Block.one, leading HPC provider Northern Data, commission-free online neobroker nextmarkets, and crypto asset management group Iconic Holding.\n'

• b'Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
• If none, this should be stated.\nIs a Supplemental Form 8 attached?
• (Note 9) NO\n'

b'Rights and Issues Investment Trust PLC: Net Asset Value(s)\nDissemination of a Regulatory Announcement, transmitted by EQS Group.\nThe issuer is solely responsible for the content of this announcement.\nThe Net Asset Value (NAV) at 12/05/2021 was:\nNumber of shares in issue:\n'

b'Chelverton UK Dividend Trust plc: Net Asset Value(s)\nDissemination of a Regulatory Announcement, transmitted by EQS Group.\nThe issuer is solely responsible for the content of this announcement.\nThe Net Asset Value (NAV) at 12/05/2021 was:\nNumber of shares in issue:\n'

• In addition, the serum of vaccinated animals showed significant cross-neutralization against variants first discovered in Denmark (B.1.1.298), the UK (B.1.1.7) and South Africa (B.1.351).
• "Spurred by the emergence of virus variants that have the potential to affect the efficacy of currently approved first-generation mRNA COVID-19 vaccines, CureVac and GSK aim to jointly develop second-generation vaccine candidates that offer improved immune responses and target emerging variants.
• Combined with lower doses, these second-generation vaccines could enable also broad protection against selected strains in a multivalent vaccine format.
• In December 2020, CureVac initiated a pivotal Phase 2b/3, the HERALD study, with a 12\xc2\xb5g dose of CVnCoV.

• b'The issuer is solely responsible for the content of this announcement.\nSteinhoff International Holdings N.V. ("SIHNV" or the "Company", together with its subsidiaries, "Steinhoff" or the "Steinhoff Group") notes recent press commentary regarding a filing in the South African courts of an application for inter alia the provisional liquidation of SIHNV.\nOn 12 May 2021 entities affiliated with the former shareholders of Tekkie Town (Pty) Ltd ("Tekkie Town Claimants") filed the aforementioned application in the Western Cape Division of the High Court of South Africa.
• On 15 February 2021, the Company announced that it had resolved to lodge an application for a Dutch "suspension of payments" procedure ("Dutch SoP") with the Amsterdam District Court to implement its proposal to settle the multi-jurisdictional legacy claims against it.
• The Amsterdam District Court approved the application on the same day and appointed two administrators, namely Mr. F. Verhoeven and Mr. C.R.
• Zijderveld.\nSIHNV will oppose the application by the Tekkie Town Claimants and will vigorously defend any attempt to disrupt the proposed global settlement and the Company\'s ongoing Dutch SoP and the proper forum of the Dutch courts.

• b"Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group.\nThe issuer is solely responsible for the content of this announcement.\nGenel Energy plc ('Genel' or 'the Company'), in line with other operators, has received a letter from the Kurdistan Regional Government ('KRG') proposing an amendment to the repayment schedule for monies owed for oil sales from November 2019 to February 2020 and the suspended override from March to December 2020.
• Under the communicated revised payment terms, for each cent above a monthly dated Brent average of $50/bbl, 0.2 cents per paying interest barrel produced will be received towards monies owed (previously 0.5 cents per paying interest barrel).
• The revised payment terms are stated by the KRG to be a result of the Dated Brent price having consistently stayed well above $50/bbl, and the ongoing challenges presented by the COVID-19 pandemic in Iraq.\nThe KRG has stated that the amended payment schedule will be applied to the March 2021 invoices onwards, and that payment terms will be 60 days after the submission of invoices.\nThe KRG has also stated that, should markets see substantial volatility, it will re-evaluate this payment model.\nOverride payments, whereby Genel receives 4.5% of monthly Tawke gross field revenues, will continue.\nThe proposal has not been discussed with, or accepted by, Genel, and we look forward to discussing it with the KRG shortly.\n"

• b'The issuer is solely responsible for the content of this announcement.\nBerlin, 12 May 2021 - ACCENTRO Real Estate AG decided today to sign a termination agreement concerning the sale-and-purchase agreement for the acquisition of DIM Holding AG ("Deutsche Immobilien Management").
• The acquisition of DIM Holding AG and the signing of the sale-and-purchase agreement had been announced by ACCENTRO AG on 29 December 2020.
• Notwithstanding the rescission of the sale-and-purchase agreement, ACCENTRO AG will continue its strategic collaboration with DIM Holding AG.
• In addition, ACCENTRO has also been granted an option whereby it can continue to acquire DIM Holding AG over the next 12 months.\nLars Schriewer, CEO of ACCENTRO commented: "We will continue on our chosen path of increasing value creation through acquisitions.

• However, we recognise that some shareholders (20.65% of votes cast) chose to support this resolution.\nWe will continue to engage with shareholders on our strategy, targets and aims so as to ensure their views are fully understood.
• We will publish an update on this engagement, in accordance with the UK Corporate Governance Code, within six months of the 2021 AGM.\nAs previously announced, Professor Dame Ann Dowling and Brendan Nelson did not stand for re-election at the AGM.
• RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
• Terms and conditions relating to the use and distribution of this information may apply.